Literature DB >> 2420292

Binding of pregnancy-associated plasma protein-A (PAPP-A) to placental subfractions.

K Isaka, P Bischof.   

Abstract

Pregnancy-associated plasma protein-A (PAPP-A) has been shown to exert immunosuppressive effects both on complement and on lymphoblastogenesis. It was of interest to see whether this protein could bind to syncytiotrophoblast microvillous membranes since these represent the effective interface between fetal tissue and the immunocompetent mother. Placental subfractions were prepared according to established techniques. PAPP-A was purified from different sources (pregnancy serum and plasma, retroplacental serum, placental extracts) and labelled with radioactive iodine. It could be shown that radioactive PAPP-A, irrespective of its biological origin was primarily binding to brush border membrane preparations but that significant binding was also seen with plasma membrane preparations. The binding was specific since alpha 2-macroglobulin (a structurally related protein to PAPP-A) was unable to displace bound radioactive PAPP-A. Scatchard plot representation of the data indicated that the affinity of PAPP-A for its binding site was of the same order of magnitude as reported for the insulin or GnRH receptors of the trophoblast (Ka 2 10(7)-2.5 10(8) M-1). These results are in agreement with the immunohistochemical localization of PAPP-A on the trophoblast providing that the small binding to plasma membrane preparations is due to contamination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420292     DOI: 10.1007/bf02133855

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  23 in total

1.  Is pregnancy-associated plasma protein A (PAPP-A) an immunomodulator during human pregnancy?

Authors:  P Bischof; S Duberg; A M Schindler
Journal:  Placenta Suppl       Date:  1982

2.  Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin.

Authors:  S Belisle; J F Guevin; D Bellabarba; J G Lehoux
Journal:  J Clin Endocrinol Metab       Date:  1984-07       Impact factor: 5.958

3.  Radioimmunoassay for the measurement of pregnancy-associated plasma protein-A (PAPP-A) in humans.

Authors:  P Bischof; L Haenggeli; M T Sizonenko; W Herrmann; P C Sizonenko
Journal:  Biol Reprod       Date:  1981-06       Impact factor: 4.285

4.  Pregnancy-associated plasma protein-A: an inhibitor of the complement system.

Authors:  P Bischof
Journal:  Placenta       Date:  1981 Jan-Mar       Impact factor: 3.481

5.  Characteristics of the microvillus brush border of human placenta: insulin receptor localization in brush border membranes.

Authors:  J A Whitsett; J L Lessard
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

6.  Radioimmunoassay for pregnancy-associated plasma protein A.

Authors:  M J Sinosich; B Teisner; J Folkersen; D M Saunders; J G Grudzinskas
Journal:  Clin Chem       Date:  1982-01       Impact factor: 8.327

7.  Immunological studies of the human placenta: functional and morphological analysis of pregnancy-associated plasma protein A (PAPP-A).

Authors:  J A McIntyre; B Hsi; W P Faulk; A Klopper; R Thomson
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

8.  Interaction between heparin and human pregnancy-associated plasma protein A (PAPP-A): a simple purification procedure.

Authors:  M W Davey; B Teisner; M Sinosich; J G Grudzinskas
Journal:  Anal Biochem       Date:  1983-05       Impact factor: 3.365

9.  Pregnancy-associated plasma protein A (PAPP-A) specifically inhibits the third component of human complement (C3).

Authors:  P Bischof; A Geinoz; W L Herrmann; P C Sizonenko
Journal:  Placenta       Date:  1984 Jan-Feb       Impact factor: 3.481

10.  Purification and characterization of pregnancy associated plasma protein A (PAPP-A).

Authors:  P Bischof
Journal:  Arch Gynecol       Date:  1979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.